Found 22 matching trials
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
N/AManagements for refractory proficient mismatch repair (pMMR) or microsatell...
Location
Hunan Cancer hospital
Phase IIb Study of AST-3424 in Patients With AKR1C3-high Expressing Advanced Hepatocellular Carcinoma
PHASE2The goal of this clinical trial is to learn if drug AST-3424 works to treat...
Location
Nanjing Tianyinshan Hospital
Combined HAIC, TKI/Anti-VEGF and ICIs as Conversion Therapy for Unresectable Hepatocellular Carcinoma
N/AThis study is conducted to evaluate the efficacy, prognosis, adverse effect...
Location
The Second Affiliated Hospital of Fujian Medical University
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcinoma
PHASE2This is a single arm, nonrandomized, single center clinical study to invest...
A Clinical Study of Exploring Camrelizumab in the Treatment of Colorectal Mucinous Adenocarcinoma(MAC)
PHASE1This is an open-label, single center, non-randomized, phase โ
ก trial to eval...
Location
Zhejiang Province Cancer Hospital
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
PHASE1A study that aimed to assess the safety and anti-tumor activity of CCAR031 ...
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma
PHASE2To evaluate the efficacy and safety of the combination therapy of SH006 inj...
Location
Nanjing Tianyinshan Hospital
Efficacy and Safety Comparison Between PD-1 Inhibitor Combined With Lenvatinib or With Regorafenib For UHCC After Failure of First-line Treatment
NAThere is no definitive evidence regarding the therapeutic efficacy of PD-1 ...
Location
Sun Yat-sen University Cancer Center
GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
PHASE2In this single-center,open-label, randomized, phase II study, the efficacy ...
Regorafenib Plus PD-1 Inhibitor in Patients With Colorectal Cancer
PHASE1This study is intended to evaluate efficacy and safety of the combination o...
Location
Department of Medical Oncology, Shanghai Changzheng Hospital